Neuromarketing firm Emsense has raised $9 million in additional capital. The new round was led by an investment from Technology Partners with existing investor the Foundry Group also participating.
This funding will allow EmSense to continue its global expansion in support of its many market research partners. The funds will also enable the company to develop a large bio-sensory in-home panel – the first of its kind.
“We believe that neuromarketing is now mainstream and is poised for explosive growth. Over the past year we conducted extensive diligence on the neuromarketing space and chose EmSense based on their highly-scalable business model, numerous clients, and key market research partners,” said Roger Quy, general partner with Technology Partners.
More info: Reuters.